Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Haemonetics (HAE) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Haemonetics (HAE) over the last 17 years, with Q4 2025 value amounting to $0.96.

  • Haemonetics' EPS (Basic) rose 2800.0% to $0.96 in Q4 2025 from the same period last year, while for Dec 2025 it was $3.65, marking a year-over-year increase of 4257.81%. This contributed to the annual value of $3.33 for FY2025, which is 4359.62% up from last year.
  • As of Q4 2025, Haemonetics' EPS (Basic) stood at $0.96, which was up 2800.0% from $0.81 recorded in Q3 2025.
  • In the past 5 years, Haemonetics' EPS (Basic) ranged from a high of $1.15 in Q1 2025 and a low of -$0.22 during Q2 2021
  • Over the past 5 years, Haemonetics' median EPS (Basic) value was $0.64 (recorded in 2022), while the average stood at $0.55.
  • In the last 5 years, Haemonetics' EPS (Basic) crashed by 16261.69% in 2021 and then soared by 53333.33% in 2022.
  • Over the past 5 years, Haemonetics' EPS (Basic) (Quarter) stood at $0.29 in 2021, then skyrocketed by 124.14% to $0.65 in 2022, then dropped by 4.62% to $0.62 in 2023, then grew by 20.97% to $0.75 in 2024, then rose by 28.0% to $0.96 in 2025.
  • Its EPS (Basic) was $0.96 in Q4 2025, compared to $0.81 in Q3 2025 and $0.71 in Q2 2025.